Endothelial destabilization by angiopoietin-2 via integrin β1 activation
Open accessThe DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index; 12 of the 35 sources its claims cite were checked for support.
Abstract
Angiopoietin-2 activates β1-integrin and promotes endothelial destabilization, including changes in VE-cadherin junctions and transendothelial tumour-cell migration.
Overview
CoChat Summary
TL;DR
Angiopoietin-2 (Ang2), but not Ang1, directly activates β1-integrin and promotes endothelial destabilization via Tie2-independent signaling. This mechanism involves Ang2 N-terminal domains, β1-integrin-dependent matrix adhesions and stress fibers, and is blocked by membrane-bound Tie2 ectodomain.
Key findings
- Ang2 activates β1-integrin in endothelial and non-endothelial cells; Ang1 does not. In CHO-cell fibronectin-binding assays, 150 nM (10 μg ml−1) Ang2 stimulated FN7–10 binding as well as ectopic talin head domain expression, whereas Ang1 had no effect even at higher concentrations.
- Tie2 silencing in human dermal blood microvascular endothelial cells (BECs) induced elongated morphology, loss of cortical actin, actin stress fibers, reduced VE-cadherin/β-catenin at cell–cell contacts, and increased active β1-integrin in central elongated adhesions. These changes were rescued by Ang2+Tie2 double silencing, β1-integrin silencing, PI3K inhibition, Rho kinase inhibition, or expression of membrane-bound murine Tie2 ectodomain (mTie2-ECD).
- Ang2 bound directly to the β1-integrin subunit in ELISA. The Ang2 N-terminal superclustering/coiled-coil domains promoted β1-integrin activation and stress fibers, whereas Ang1–Ang2 chimeras and angiopoietin FLD-Fc proteins did not activate β1-integrin.
- In VEC-tTA/Tet-OS-Ang2 transgenic mice, aortic endothelium showed more irregular VE-cadherin staining, central active β1-integrin adhesions, central actin fibers, and reduced junctional Tie2 compared with wild-type mice. Ang2-blocking antibodies inhibited transendothelial migration of LNM-35 cells, while Tie2-silenced endothelium was more permissive for LLC-GFP transmigration.
Methods
- Cell models: human dermal BECs, human pulmonary microvascular endothelial cells, HeLa, CHO, LLC, and LNM-35 cells; shRNA/siRNA silencing of Tie2, Ang2, Tie1, β1-integrin, αv, β3, and β5; angiopoietin stimulation with recombinant human Ang1/Ang2 (60 nM, 4 μg ml−1, 30 min for HeLa).
- Assays: immunofluorescence for actin, VE-cadherin, β-catenin, ZO-1, active β1-integrin, CD31, and Tie2; adhesion and fibronectin matrix remodeling assays; Transwell tumour-cell transmigration; FACS-based integrin activation assay using Alexa-647-conjugated fibronectin fragment FN7–10 normalized to total α5β1; ELISA for Ang2–β1-integrin binding.
- In vivo: VEC-tTA/Tet-OS-Ang2 mice with postnatal endothelial Ang2 induction; en face whole-mount staining of mouse aorta for VE-cadherin, CD31, active β1-integrin, F-actin, and Tie2. Statistics used Student’s t-test (two-tailed, unequal variance) and Dunnett’s test; P < 0.05 considered significant.
Limitations
- The paper states that its results “do not rule out additional interactions with β1-integrin, mediated via the C-terminal domains of Ang2 or Ang1.”
- For the Ang2 transgenic mouse phenotype, the paper states that “the mechanism remains to be fully elucidated.”
- Evident from the text: much of the mechanistic evidence comes from Tie2-silenced cultured endothelial cells and HeLa/CHO overexpression or recombinant systems; in vivo evidence is limited to aortic endothelium of Ang2 transgenic mice, without direct in vivo β1-integrin blockade.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
12 Valid · 0 Not valid · 21 Not checked · 74 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“During vascular development, Ang2 inhibition blocked VE-cadherin phosphorylation at tyrosine residue 685 and the concomitant formation of button-like junctions in initial lymphatic vessels20”
§ Endothelial destabilization by angiopoietin-2 via integrin β1 activation > Abstract
What the sources say
- Supportedcites [20] Zheng, W et al. Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions. Genes Dev. 28, 1592–1603 (2014). source
The Results section reports that ANG2 blockade left little VE-cadherin phosphorylation at Y685 in embryonic initial lymphatics and that the junctions failed to transform from zippers to buttons at the same time. It also reports that ANG2 inhibition suppressed essentially all button formation. The claim describes these concurrent effects, not a causal link between them. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We used the VEC-tTA/Tet-OS-Ang2 mouse line, which expresses mouse Ang2 under an inducible endothelial cell promoter19.”
§ Endothelial destabilization by angiopoietin-2 via integrin β1 activation > Methods > Animal models
What the sources say
- Supportedcites [19] Holopainen, T. et al. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J. Natl Cancer Inst. 104, 461–475 (2012). source
The Methods (Mice) describe a responder construct containing the full-length mouse Ang2 coding sequence under a tetracycline-responsive promoter, bred with a VE-cadherin-tTA driver line. The Results (The Effect of Ang2 Overexpression on Metastasis of Human Lung Carcinoma Xenografts) state that this construct drives endothelial Ang2 expression when tetracycline is discontinued. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We found that antibodies blocking the Ang2–Tie2 interaction reduced tumour cell transendothelial migration, in line with previously published in vivo data19.”
§ Endothelial destabilization by angiopoietin-2 via integrin β1 activation > Results and Discussion > Changes in the aortic endothelium of Ang2 transgenic mice
What the sources say
- Partly supportedcites [19] Holopainen, T. et al. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J. Natl Cancer Inst. 104, 461–475 (2012). sourceExperimental — accuracy not yet measured
The Discussion reports fewer early lung tumour-cell colonies after Ang2-blocking antibody treatment and suggests that blocking Ang2 may inhibit extravasation. It also states that extravasation was not imaged, so the paper provides consistent in vivo evidence rather than a direct finding of reduced transendothelial migration. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“To overcome the embryonic lethality due to endothelial Ang2 overexpression in double-transgenic embryos, Ang2 expression was repressed during the entire pregnancy.”
§ Endothelial destabilization by angiopoietin-2 via integrin β1 activation > Methods > Animal models
What the sources say
- Supportedcites [19] Holopainen, T. et al. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J. Natl Cancer Inst. 104, 461–475 (2012). source
The Methods > Mice passage explicitly says that endothelial Ang2 overexpression caused embryonic lethality in double-transgenic embryos and that Ang2 expression was repressed throughout pregnancy to overcome it. No page number is provided in our copy. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“Of note, a 150 nM (10 μg ml−1) concentration of Ang2 stimulated FN7–10 binding to CHO cells equally well as the ectopic expression of the talin head domain, a prominent inside-out activator of β1-integrin44.”
§ Endothelial destabilization by angiopoietin-2 via integrin β1 activation > Results and Discussion > Ang2, but not Ang1, activates β1-integrin
What the sources say
- Not checked yetcites [44] Calderwood, D. A. et al. The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J. Biol. Chem. 274, 28071–28074 (1999). source
Checked before — its earlier verdict is held back until a new check runs.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not checked yet
48 more claims
Create a free account to see all 107 claims and to verify the 3 references still open.
- Probably not a substantial claim. 10
- It may state two separate claims as one. 48
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, ANGPT2 was recently reported to activate α5β1-integrin, leading to endothelial monolayer destabilization (15).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We previously showed that, in addition to TIE2, ANGPT2 can signal via α5β1-integrin, leading to destabilization of EC monolayers where TIE2 levels are low (15).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“Recent studies have demonstrated that beyond the primary signaling mode through TIE2, ANGPTs can also signal via integrins to modulate vascular responses (13, 21–25).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Because we previously found that the ANGPT2 N-terminus, but not that of ANGPT1, activated α5β1-integrin (22), and here we further show that the ANGPT1 N-terminus does not bind β1-integrin, these data suggest ANGPT2 may facilitate α5β1-integrin activation by interacting with the hybrid/PSI domain in a unique manner not mediated by ANGPT1.”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [22]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“By contrast, β3-integrin (shβ3) silencing decreased VE-cadherin in BECs, in line with previous studies (9, 15), and shβ3 did not prevent the thrombin-induced loss of VE-cadherin (Fig. 2 C and D and SI Appendix, Fig. S3A).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [15]
Experimental — accuracy not yet measured
Citations
Cites
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Chiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
Partitioning of Lipid-Modified Monomeric GFPs into Membrane Microdomains of Live Cells
Zacharias, D. A., Violin, J. D., Newton, A. C., & Tsien, R. Y. (2002) · Science · doi:10.1126/science.1068539 · Cited by 2,235
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Self-citationDumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A., & Breitman, M. L. (1994) · Genes & Development · doi:10.1101/gad.8.16.1897 · Cited by 985
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922
Ory, D. S., Neugeboren, B. A., & Mulligan, R. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11400 · Cited by 912
Cited by
Every step of the way: integrins in cancer progression and metastasis
Hamidi, H., & Ivaska, J. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0038-z · Cited by 1,493
Self-citationTherapeutic strategies for enhancing angiogenesis in wound healing
Veith, A. P., Henderson, K., Spencer, A., Sligar, A. D., & Baker, A. B. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.010 · Cited by 1,021
Kidney fibrosis: from mechanisms to therapeutic medicines
Huang, R., Fu, P., & Ma, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01379-7 · Cited by 781
“Inflammation and hypoxia triggered endothelial cell angpt2 expression,(143) which could destabilized the integrity of endothelium.(144) A latest published study has proven that angpt2 inhibition by angpt1 or a Fc-fusion peptide L1-10 could attenuate endothelial inflammation, apoptosis, and renal fibrosis in progressiv…”
BackgroundNanocomposite scaffolds for accelerating chronic wound healing by enhancing angiogenesis
Nosrati, H., Aramideh Khouy, R., Nosrati, A., Khodaei, M., Banitalebi-Dehkordi, M., Ashrafi-Dehkordi, K., Sanami, S., & Alizadeh, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00755-7 · Cited by 720
“Tie2 is the receptor for ANGPT ligands and researchers have recently demonstrated the regulatory effects of Tie1 on Tie2 tyrosine kinase activity [42].”
BackgroundPermeability of the Endothelial Barrier: Identifying and Reconciling Controversies
Claesson-Welsh, L., Dejana, E., & McDonald, D. M. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.11.006 · Cited by 631
“The antagonistic effects of Angpt2 are also influenced by binding to and activation of beta-1 integrins [80].”
BackgroundTherapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
Self-citationRole of Angiopoietin-2 in Vascular Physiology and Pathophysiology
Akwii, R. G., Sajib, M. S., Zahra, F. T., & Mikelis, C. M. (2019) · Cells · doi:10.3390/cells8050471 · Cited by 543
“Moreover, β1 integrin binding and activation was Ang2-specific, but not Ang1, and expression of a membrane-bound Tie2 lacking the kinase activity blocked the activation of the integrins by Ang2 [124].”
BackgroundIntegrin trafficking in cells and tissues
Moreno-Layseca, P., Icha, J., Hamidi, H., & Ivaska, J. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0223-z · Cited by 464
Self-citationFang, J., Zhang, Z., Shang, L., Luo, Y., Lin, Y., Yuan, Y., & Zhuang, S. (2018) · Hepatology · doi:10.1002/hep.29920 · Cited by 335
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J.-B., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 327
Targeting angiogenesis in oncology, ophthalmology and beyond
Cao, Y., Langer, R., & Ferrara, N. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00671-z · Cited by 315
The effects of sepsis on endothelium and clinical implications
Dolmatova, E. V., Wang, K., Mandavilli, R., & Griendling, K. K. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa070 · Cited by 317
Joussen, A. M., Ricci, F., Paris, L. P., Korn, C., Quezada-Ruiz, C., & Zarbin, M. (2021) · Eye · doi:10.1038/s41433-020-01377-x · Cited by 290
“promotes changes in the actin cytoskeleton, affecting vascular endothelial cadherin-mediated EC–EC adhesion and cell–extracellular matrix adhesion, resulting in vascular destabilisation [19].”
BackgroundTie1 controls angiopoietin function in vascular remodeling and inflammation
Korhonen, E. A., Lampinen, A., Giri, H., Anisimov, A., Kim, M., Allen, B., Fang, S., D’Amico, G., Sipilä, T. J., Lohela, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84923 · Cited by 283
“In contrast, ANG2 can activate β1 integrin directly, independent of Tie2 (38, 40), which promotes radial stress fiber formation, endothelial destabilization (40), and pericyte detachment (39).”
BackgroundSelf-citationCell–matrix signals specify bone endothelial cells during developmental osteogenesis
Langen, U. H., Pitulescu, M. E., Kim, J. M., Enriquez-Gasca, R., Sivaraj, K. K., Kusumbe, A. P., Singh, A., Di Russo, J., Bixel, M. G., Zhou, B., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3476 · Cited by 254
Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation
Kim, M., Allen, B., Korhonen, E. A., Nitschké, M., Yang, H. W., Baluk, P., Saharinen, P., Alitalo, K., Daly, C., Thurston, G., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84871 · Cited by 243
Self-citationRen, T., Zhang, H., Wang, J., Zhu, J., Jin, M., Wu, Y., Guo, X., Ji, L., Huang, Q., Zhang, H., et al. (2017) · Oncogene · doi:10.1038/onc.2017.167 · Cited by 205
Frye, M., Dierkes, M., Küppers, V., Vockel, M., Tomm, J., Zeuschner, D., Rossaint, J., Zarbock, A., Koh, G. Y., Peters, K., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150718 · Cited by 222
“These are VE-cadherin itself and plakoglobin (Nottebaum et al., 2008; Wessel et al., 2014) and VEG FR-2 (Hayashi et al., 2013), which are involved in the regulation of junctions.”
BackgroundInfluentialAngiopoietin–Tie signalling in the cardiovascular and lymphatic systems
Eklund, L., Kangas, J., & Saharinen, P. (2017) · Clinical Science · doi:10.1042/cs20160129 · Cited by 202
Self-citationCOVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
Smadja, D. M., Mentzer, S. J., Fontenay, M., Laffan, M. A., Ackermann, M., Helms, J., Jonigk, D., Chocron, R., Pier, G. B., Gendron, N., et al. (2021) · Angiogenesis · doi:10.1007/s10456-021-09805-6 · Cited by 200
Angiopoietin-1 is required for Schlemm’s canal development in mice and humans
Thomson, B. R., Souma, T., Tompson, S. W., Onay, T., Kizhatil, K., Siggs, O. M., Feng, L., Whisenhunt, K. N., Yanovitch, T. L., Kalaydjieva, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95545 · Cited by 171
Contribution of adipose tissue to development of cancer
Cozzo, A. J., Fuller, A. M., & Makowski, L. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170008 · Cited by 188
Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma
Huang, R., & Rofstad, E. K. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0763-x · Cited by 177
Faricimab Treat-and-Extend for Diabetic Macular Edema
Wong, T. Y., Haskova, Z., Asik, K., Baumal, C. R., Csaky, K. G., Eter, N., Ives, J. A., Jaffe, G. J., Korobelnik, J.-F., Lin, H., et al. (2024) · Ophthalmology · doi:10.1016/j.ophtha.2023.12.026 · Cited by 176
Sun, Y., Chen, W., Torphy, R. J., Yao, S., Zhu, G., Lin, R., Lugano, R., Miller, E. N., Fujiwara, Y., Bian, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc8922 · Cited by 174
Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction
Lee, S.-J., Lee, C.-K., Kang, S., Park, I., Kim, Y. H., Kim, S. K., Hong, S. P., Bae, H., He, Y., Kubota, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99659 · Cited by 164
Tabit, C. E., Chen, P., Kim, G. H., Fedson, S., Sayer, G. T., Coplan, M. J., Jeevanandam, V., Uriel, N. Y., & Liao, J. K. (2016) · Circulation · doi:10.1161/circulationaha.115.019692 · Cited by 160
Biomarkers for Sepsis: What is and What Might Be?
Girard, B., Ayala, A., & Lomas‐Neira, J. (2015) · Biomarker Insights · doi:10.4137/bmi.s29519 · Cited by 149
Endothelial glycocalyx breakdown is mediated by angiopoietin-2
Lukasz, A. H., Hillgruber, C., Oberleithner, H., Kusche‐Vihrog, K., Pavenstädt, H., Rovas, A., Hesse, B., Goerge, T., & Kümpers, P. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx023 · Cited by 152
Perez, V. M., Kearney, J. F., & Yeh, J. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.751311 · Cited by 143
Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP
Souma, T., Thomson, B. R., Heinen, S., Anna Carota, I., Yamaguchi, S., Onay, T., Liu, P., Ghosh, A. K., Li, C., Eremina, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714446115 · Cited by 135
“Additionally, ANGPT2 exerts proangiogenic/ vascular-destabilizing signals through integrin-mediated pathways (46, 47).”
Angiopoietins and Tie2 in vascular inflammation
Parikh, S. M. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000361 · Cited by 132
Vascular leak in sepsis: physiological basis and potential therapeutic advances
McMullan, R. R., McAuley, D. F., O’Kane, C. M., & Silversides, J. A. (2024) · Critical Care · doi:10.1186/s13054-024-04875-6 · Cited by 166
“In addition to Tie-2 antagonism, Ang-2 has been revealed to directly activate β 1-integrin which resulted in cytoskeleton reorganisation and destabilization of intercellular junctions via increased cell contractility [84].”
BackgroundIntegrin-Dependent Cell–Matrix Adhesion in Endothelial Health and Disease
Aman, J., & Margadant, C. (2023) · Circulation Research · doi:10.1161/circresaha.122.322332 · Cited by 129
THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES: A Review
Heier, J. S., Singh, R. P., Wykoff, C. C., Csaky, K. G., Lai, T. Y. Y., Loewenstein, A., Schlottmann, P. G., Paris, L. P., Westenskow, P. D., & Quezada-Ruiz, C. (2020) · Retina · doi:10.1097/iae.0000000000003003 · Cited by 124
Fang, Z., Tian, Y., Sui, C., Guo, Y., Hu, X., Lai, Y., Liao, Z., Li, J., Feng, G., Jin, L., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.919731 · Cited by 124
“ANGPT2 mediated β1-integrin (ITGB1) activation and elongated matrix adhesions and actin stress fibers, regulating vascular endothelial cells’ cadherin-containing cell–cell junctions (Hakanpaa et al., 2015).”
BackgroundFlaumenhaft, R. C., Enjyoji, K., & Schmaier, A. A. (2022) · Blood · doi:10.1182/blood.2021012250 · Cited by 130
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer
Blandin, A.-F., Renner, G., Lehmann, M., Lelong-Rebel, I. H., Martin, S., & Dontenwill, M. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00279 · Cited by 112
Gene control of tyrosine kinase TIE2 and vascular manifestations of infections
Ghosh, C. C., David, S., Zhang, R., Berghelli, A. V., Milam, K. E., Higgins, S. J., Hunter, J. T., Mukherjee, A., Wei, Y., Tran, M. T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519467113 · Cited by 106
“Similar protective effects arise with blockade, deletion, or depletion of Angpt-2 (1, 4, 6, 30).”
BackgroundInfluentialTargeting endothelial permeability in the EPR effect
Lahooti, B., Akwii, R. G., Zahra, F. T., Sajib, M. S., Λάμπρου, Μ., Alobaida, A., Lionakis, M. S., Mattheolabakis, G., & Mikelis, C. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.039 · Cited by 119
Targeting β1-integrin inhibits vascular leakage in endotoxemia
Hakanpaa, L., Kiss, E. A., Jacquemet, G., Miinalainen, I., Lerche, M., Guzmán, C., Mervaala, E., Eklund, L., Ivaska, J., & Saharinen, P. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722317115 · Cited by 95
“β1-integrin, which is the major integrin subunit expressed by ECs (11, 12, 15), was simultaneously inhibited with β1-integrin antibody (mAb13).”
BackgroundResultInfluentialSelf-citationNanomaterials for Angiogenesis in Skin Tissue Engineering
Cui, L., Liang, J., Liu, H., Zhang, K., & Li, J. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0337 · Cited by 96
Leong, A., & Kim, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228689 · Cited by 101
“Here, TIE2 likely acts as a ligand trap to inhibit endothelial ANG2-β1-integrin signaling [52].”
BackgroundJha, S. K., Rauniyar, K., Kärpänen, T., Leppänen, V., Brouillard, P., Vikkula, M., Alitalo, K. K., & Jeltsch, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-04982-1 · Cited by 88
Self-citationCytokines regulating lymphangiogenesis
Sáinz‐Jaspeado, M., & Claesson, L. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.04.003 · Cited by 79
Cell matrix adhesion in cell migration
Conway, J. R. W., & Jacquemet, G. (2019) · Essays in Biochemistry · doi:10.1042/ebc20190012 · Cited by 103
Self-citationSignaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao, R. Y., Tian, H., Zhang, Y., Liu, G., Xu, H., Rao, G., Tian, Y., & Fu, X. (2023) · MedComm · doi:10.1002/mco2.283 · Cited by 108
Plectin reinforces vascular integrity by mediating vimentin-actin network crosstalk
Osmanagic‐Myers, S., Lehr, S., Wolfram, M., Brunner, D., Goldmann, W. H., Bonakdar, N., Fischer, I., Reipert, S., Zuzuarregui, A., Walko, G., et al. (2015) · Journal of Cell Science · doi:10.1242/jcs.172056 · Cited by 93
“Consistent with previous reports (Chiu and Chien, 2011; Hakanpaa et al., 2015; Melchior and Frangos, 2010), in situ immunolabelling of P+/− specimens for VE-cadherin revealed a mostly linear lining of cells in high-flow regions of the aortic arch outer curvature, whereas the patterns observed in…”
BackgroundResultAscending Vasa Recta Are Angiopoietin/Tie2-Dependent Lymphatic-Like Vessels
Kenig-Kozlovsky, Y., Scott, R. P., Onay, T., Carota, I. A., Thomson, B. R., Gil, H. J., Ramirez, V., Yamaguchi, S., Tanna, C. E., Heinen, S., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017090962 · Cited by 79
Huang, L., Bichsel, C. A., Norris, A. L., Thorpe, J., Pevsner, J., Alexandrescu, S., Pinto, A., Zurakowski, D., Kleiman, R. J., Sahin, M., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316651 · Cited by 72
Hove, I. V., Hu, T., Beets, K., Bergen, T. V., Etienne, I., Stitt, A. W., Vermassen, E., & Feyen, J. H. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100966 · Cited by 81
Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions
Lerma-Martin, C., Badia-i-Mompel, P., Ramirez Flores, R. O., Sekol, P., Schäfer, P. S. L., Riedl, C. J., Hofmann, A., Thäwel, T., Wünnemann, F., Ibarra-Arellano, M. A., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01796-z · Cited by 76
Angiopoietins and diabetic nephropathy
Gnudi, L. (2016) · Diabetologia · doi:10.1007/s00125-016-3995-3 · Cited by 74
Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor
Daly, C., Qian, X., Castanaro, C., Pasnikowski, E. M., Jiang, X., Thomson, B. R., Quaggin, S. E., Papadopoulos, N. J., Wei, Y., Rudge, J. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18912-8 · Cited by 62
Feghhi, M., Rezaie, J., Akbari, A., Jabbari, N., Jafari, H., Seidi, F., & Szafert, S. (2020) · Materials & Design · doi:10.1016/j.matdes.2020.109227 · Cited by 66
Roles of Biomarkers in Myocardial Fibrosis
Ding, Y., Wang, Y., Zhang, W., Jia, Q., Wang, X., Li, Y., Lv, S., & Zhang, J. (2020) · Aging and Disease · doi:10.14336/ad.2020.0604 · Cited by 74
“TIMP1 mediates the interaction between fibroblast membrane protein CD63 and integrin β1, which is widely expressed in various cells, thus triggering fibrosis [52-55].”
BackgroundRole of Angiopoietins in Development of Cancer and Neoplasia Associated with Viral Infection
Yu, X., & Ye, F. (2020) · Cells · doi:10.3390/cells9020457 · Cited by 68
“demonstrated that Ang-2 destabilization of existing blood vessels also depended on Ang-2-mediated activation of integrin-β1 [12].”
BackgroundEndothelial Palmitoylation Cycling Coordinates Vessel Remodeling in Peripheral Artery Disease
Wei, X., Adak, S., Zayed, M. A., Li, Y., Chu, F., Speck, S. L., Kathayat, R. S., Zhang, Q., Dickinson, B. C., & Semenkovich, C. F. (2020) · Circulation Research · doi:10.1161/circresaha.120.316752 · Cited by 57
Li, X., Zhang, S., Xu, W. B., Xing, B., Lu, Q., Zhang, P., Li, H., Zhang, L., Zhang, W.-C., Chen, W., et al. (2018) · Virology · doi:10.1016/j.virol.2018.05.001 · Cited by 50
Lu, R. X. Z., Lai, B. F. L., Rafatian, N., Gustafson, D., Campbell, S. B., Banerjee, A., Kozak, R., Mossman, K., Mubareka, S., Howe, K. L., et al. (2022) · Lab on a Chip · doi:10.1039/d1lc00817j · Cited by 58
Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice
Theelen, T. L., Lappalainen, J. P., Sluimer, J. C., Gurzeler, E., Cleutjens, J. P., Gijbels, M. J., Biessen, E. A. L., Daemen, M. J. A. P., Alitalo, K., & Ylä-Herttuala, S. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.018 · Cited by 58
“Ang-2 is known to induce endothelial destabilization and vascular permeability [36], thus suggesting a beneficial effect of Ang-2 blockage.”
BackgroundSelf-citationPedrosa, A., Bodrug, N., Gómez-Escudero, J., Carter, E. P., Reynolds, L. E., Georgiou, P. N., Fernandez, I., Lees, D. M., Kostourou, V., Alexopoulou, A. N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3934 · Cited by 61
“This leaves Ang2 free to bind and activate b1 integrins and in turn activate downstreamphosphorylation of FAK-Y397 to induce sprouting (26, 29).”
BackgroundResultAngiopoietin 2 signal complexity in cardiovascular disease and cancer
Nicolini, G., Forini, F., Kusmic, C., Iervasi, G., & Balzan, S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117080 · Cited by 63
Jabbari, N., Nawaz, M., & Rezaie, J. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0474-8 · Cited by 59
Zadorozhna, M., Gioia, S. D., Conese, M., & Mangieri, D. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05290-0 · Cited by 60
“Ang-2 is acutely released from activated ECs/LSECs, upon stimulation with inflammatory cytokines, proangiogenic factors, and hypoxia and competitively inhibits the binding of Ang-1 to Tie-2 [59] that, instead, serves to maintain survival and quiescence of endothelium [60].”
BackgroundKhan, K. A., Wu, F. T. H., Cruz‐Muñoz, W., & Kerbel, R. S. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.201708253 · Cited by 55
“…engagement, Ang1 and Ang2 also differ with respect to extracellular matrix binding (Xu & Yu, 2001), as well as effects on Tie1-Tie2 heterodimers (Seegar et al, 2010; D’Amico et al, 2014; Savant et al, 2015) and activation of integrins (Felcht et al, 2012; Lee et al, 2013; Hakanpaa et al, 2015).”
Endothelial Cell Responses to Biomechanical Forces in Lymphatic Vessels
Sabine, A., Demir, C. S., & Petrova, T. V. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6685 · Cited by 57
Tie2 Activation Promotes Protection and Reconstitution of the Endothelial Glycocalyx in Human Sepsis
Drost, C. C., Rovas, A., Kusche‐Vihrog, K., Slyke, P. V., Kim, H. L., Hoang, V. C., Maynes, J. T., Wennmann, D. O., Pavenstädt, H., Linke, W. A., et al. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1695768 · Cited by 61
Canonica, J., Foxton, R. H., Garrido, M. G., Lin, C., Uhles, S., Shanmugam, S., Antonetti, D. A., Abcouwer, S. F., & Westenskow, P. D. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1192464 · Cited by 63
“Findings from preclinical studies suggest that Ang-2 can both alter Tie2 signaling and activate integrin signaling, leading to angiogenesis and endothelial de-stabilization (Felcht et al., 2012; Hakanpaa et al., 2015).”
BackgroundRezaie, J., Mehranjani, M. S., Rahbarghazi, R., & Shariatzadeh, S. M. A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26211 · Cited by 55
“Ang-1 and -2 participate in the dynamic of vascular bed [Augustin et al., 2009; Lee et al., 2013; Hakanpaa et al., 2015].”
BackgroundA collagen IV–derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling
Mirando, A. C., Shen, J., Silva, R. L. E., Chu, Z., Sass, N. C., Lorenc, V. E., Green, J. J., Campochiaro, P. A., Popel, A. S., & Pandey, N. B. (2019) · JCI Insight · doi:10.1172/jci.insight.122043 · Cited by 57
Angiogenic Self-Assembling Peptide Scaffolds for Functional Tissue Regeneration
Sarkar, B., Nguyen, P. K., Gao, W., Dondapati, A., Siddiqui, Z., & Kumar, V. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b01137 · Cited by 52
Zhang, L., Qian, Z., Tahtinen, M., Qi, S., & Zhao, F. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2512 · Cited by 42
Williams, S. P., Odell, A. F., Karnezis, T., Farnsworth, R. H., Gould, C. M., Li, J., Paquet‐Fifield, S., Harris, N. C., Walter, A., Gregory, J. L., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal2987 · Cited by 49
“- 12 regulates developmental lymphatic migration and remodelling (25, 31), and triggers stress fibre formation at the expense of cell-cell junction integrity in BECs by activating integrin-β1 (32).”
BackgroundLi, Z., Korhonen, E. A., Merlini, A., Strauss, J., Wihuri, E., Nurmi, H., Antila, S., Paech, J., Deutsch, U., Engelhardt, B., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130308 · Cited by 52
Self-citationEndothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
Jiang, X., Tian, W., Tu, A. B., Pasupneti, S., Shuffle, E. M., Dahms, P. A., Zhang, P., Cai, H., Dinh, T. T., Liu, B., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036157 · Cited by 56
Bae, H., Hong, K. Y., Lee, C.-K., Jang, C., Lee, S.-J., Choe, K., Offermanns, S., He, Y., Lee, H. J., & Koh, G. Y. (2020) · Nature Communications · doi:10.1038/s41467-020-16795-4 · Cited by 52
Poto, R., Loffredo, S., Palestra, F., Marone, G., Patella, V., & Varricchi, G. (2022) · Cells · doi:10.3390/cells11101720 · Cited by 58
“bind to and signal via integrin heterodimers [47,48].”
BackgroundCharacterization of ANGPT2 mutations associated with primary lymphedema
Leppänen, V.-M., Brouillard, P., Korhonen, E. A., Sipilä, T., Jha, S. K., Revencu, N., Labarque, V., Fastré, E., Schlögel, M., Ravoet, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax8013 · Cited by 49
Self-citationAgostini, H., Abreu, F. M., Baumal, C. R., Chang, D. S.-T., Csaky, K. G., Demetriades, A. M., Kodjikian, L., Lim, J. I., Margaron, P., Monés, J., et al. (2024) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-024-06531-9 · Cited by 57
Zhang, J., Li, L., Peng, Y., Chen, Y., Lv, X., Li, S., Qin, X., Yang, H., Wu, C., & Liu, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.10.007 · Cited by 41
Endothelial dysfunction: a therapeutic target in bacterial sepsis?
Vincent, J., İnce, C., & Pickkers, P. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1988928 · Cited by 48
“Angiopoietin 1 (Angpt-1) is the main agonist of the Tie-2 receptor to enhance its endothelial stabilizing activity, whereas angiopoietin II (Angpt-2) can destabilize the endothelial barrier [69] by promoting β1-integrin activation,”
BackgroundTee, J. K., Setyawati, M. I., Fei, P., Leong, D. T., & Ho, H. K. (2019) · Nanotoxicology · doi:10.1080/17435390.2019.1571646 · Cited by 45
“Data represent means ± SEM, n = 3, p < 0.05. maintaining the integrity of the endothelial monolayer (Frye et al. 2015; Hakanpaa et al. 2015).”
BackgroundMethodInfluentialAngiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential
Whitehead, M., Osborne, A., Widdowson, P. S., Yu‐Wai‐Man, P., & Martin, K. R. G. (2019) · Journal of Diabetes Research · doi:10.1155/2019/5140521 · Cited by 44
“Interestingly, Ang2 has been shown to activate β1-integrins in order to promote vascular destabilisation via the regulation of VE-cadherin-containing cell-cell junctions (Figure 1) [46].”
BackgroundHong, L., Li, F., Tang, C., Li, L., Sun, L., Li, X., & Zhu, L. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02818-x · Cited by 47
Sheng, X., Zhang, C., Zhao, J., Xu, J., Zhang, P., Ding, Q., & Zhang, J. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01269-7 · Cited by 58
“Beside Tie2 receptor, Ang-2 can also bind to integrin receptor to aggravate vascular destabilization [199, 200].”
BackgroundVascular growth factors play critical roles in kidney glomeruli
Gnudi, L., Benedetti, S., Woolf, A. S., & Long, D. A. (2015) · Clinical Science · doi:10.1042/cs20150403 · Cited by 46
Review of the endothelial pathogenic mechanism of TIE2-related venous malformation
Du, Z., Zheng, J., Zhang, Z., & Wang, Y. (2017) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2017.05.001 · Cited by 47
Dalton, A. C., Shlamkovich, T., Papo, N., & Barton, W. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163732 · Cited by 45
MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells
Wang, H., Hang, C., Ou, X., Nie, J., Ding, Y.-T., Xue, S.-G., Gao, H., & Zhu, J. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0331-4 · Cited by 48
Angiopoietin-1 deficiency increases tumor metastasis in mice
Michael, I. P., Orebrand, M., Lima, M. C., Pereira, B. D. A., Volpert, O. V., Quaggin, S. E., & Jeansson, M. (2017) · BMC Cancer · doi:10.1186/s12885-017-3531-y · Cited by 44
“Angpt2 can activate integrins, leading to endothelial destabilization [7], an effect that may be increased in situations of low Tek expression [8].”
Maliken, B. D., Kanisicak, O., Karch, J. M., Khalil, H., Fu, X., Boyer, J. G., Prasad, V., Zheng, Y., & Molkentin, J. D. (2018) · Circulation · doi:10.1161/circulationaha.118.033703 · Cited by 37
Stritt, S., Nurden, P., Nurden, A. T., Schved, J., Bordet, J., Roux, M., Alessi, M., Trégouët, D., Mäkinen, T., & Giansily‐Blaizot, M. (2022) · Haematologica · doi:10.3324/haematol.2022.280816 · Cited by 42
Miteva, K. T., Pedicini, L., Wilson, L. A., Jayasinghe, I., Slip, R. G., Marszalek, K., Gaunt, H. J., Bartoli, F., Deivasigamani, S., Sobradillo, D., et al. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201810118 · Cited by 36
The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis
Li, X., Li, Y., Lu, W., Chen, M., Ye, W., & Zhang, D. (2019) · Cells · doi:10.3390/cells8121602 · Cited by 41
“Except for tumor cells, endothelial cells automatically produce angiopoietin 2 (Ang2), which interacts with integrinβ1 and results in reduced barrier function, leading to enhanced transendothelial migration [20].”
BackgroundGupta, P., Moses, J. C., & Mandal, B. B. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01194 · Cited by 35
Motallebnejad, P., & Azarin, S. M. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00215-2 · Cited by 32
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
Shafqat, A., Shafqat, S., Alsalameh, S., Kashir, J., AlKattan, K. M., & Yaqinuddin, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835104 · Cited by 38
Integrin β1 in Pancreatic Cancer: Expressions, Functions, and Clinical Implications
Li, J., Peng, L., Chen, Q., Ye, Z., Zhao, T., Hou, S., Gu, J., & Hang, Q. (2022) · Cancers · doi:10.3390/cancers14143377 · Cited by 34
Hu, T., Vanhove, M., Porcu, M., Hove, I. V., Bergen, T. V., Jonckx, B., Barbeaux, P., Vermassen, E., & Feyen, J. H. M. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.11.022 · Cited by 36
Metadata
- Authors
- Hakanpaa, L., Sipila, T., Leppanen, V.-M., Gautam, P., Nurmi, H., Jacquemet, G., Eklund, L., Ivaska, J., Alitalo, K., & Saharinen, P.
- Affiliations
- University of Helsinki (FI)
- University of Turku (FI)
- University of Oulu (FI)
- Corresponding author
- Saharinen, Pipsa
- ORCID
- Venue
- Nature Communications
- Published
- 2015-01-30
- Volume
- 6
- Issue
- 1
- Pages
- 5962-5962
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4316742
- OpenAlex
- W2077884715
- Cited by
- 287
- References
- 56
- Citations by year
- 2026: 23 · 2025: 19 · 2024: 31 · 2023: 22 · 2022: 28 · 2021: 27 · 2020: 32 · 2019: 23 · 2018: 23 · 2017: 26 · 2016: 19 · 2015: 12
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Åbo Akademi University Research Portal (submittedVersion)
- Funders
- Fondation Leducq (11CVD03)
- Academy of Finland (20122017, 2014–2019, 271845, 136880)
- FP7 Ideas: European Research Council (268804)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- angiopoietin-2, angiopoietin-1, beta1 integrin, Tie2 receptor, vascular permeability, pathological angiogenesis, stress fibers, cell-matrix adhesion, phosphatidylinositol 3-kinase, Rho kinase
- MeSH terms
- Animals, Cell Line, Female, Humans, Male, Mice, Transgenic, Pregnancy, Integrin beta1, Angiopoietin-1, Angiopoietin-2, Endothelial Cells, Receptor, TIE-2, Mice, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.